Neurocrine Biosciences Announces Once-Dail...
FDA Approval of ONGENTYS Supported by Data from 38 Clinical Studies, Including Two Multinational Phase III Clinical Studies (BIPARK-1 and BIPARK-2)...
Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.
Let's talkSearch our recent client collaborations below: